Peter J Friend
Overview
Explore the profile of Peter J Friend including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
118
Citations
2241
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
McCallion O, Cross A, Brook M, Hennessy C, Ferreira R, Trzupek D, et al.
Med
. 2024 Dec;
:100561.
PMID: 39731908
Background: Adoptive transfer of autologous regulatory T cells (Tregs) is a promising therapeutic strategy aimed at enabling immunosuppression minimization following kidney transplantation. In our phase 1 clinical trial of Treg...
2.
Abbas S, Ceresa C, Hodson L, Nasralla D, Watson C, Mergental H, et al.
Trials
. 2024 Jun;
25(1):386.
PMID: 38886851
Background: Liver disease is the third leading cause of premature death in the UK. Transplantation is the only successful treatment for end-stage liver disease but is limited by a shortage...
3.
Mergental H, Laing R, Kirkham A, Clarke G, Boteon Y, Barton D, et al.
Liver Transpl
. 2023 Dec;
30(1):30-45.
PMID: 38109282
Normothermic machine perfusion (NMP) enables pretransplant assessment of high-risk donor livers. The VITTAL trial demonstrated that 71% of the currently discarded organs could be transplanted with 100% 90-day patient and...
4.
Schlegel A, Mergental H, Fondevila C, Porte R, Friend P, Dutkowski P
J Hepatol
. 2023 May;
78(6):1181-1198.
PMID: 37208105
With the increasing number of accepted candidates on waiting lists worldwide, there is an urgent need to expand the number and the quality of donor livers. Dynamic preservation approaches have...
5.
Albert C, Harris M, DiRito J, Shi A, Edwards C, Harkins L, et al.
Am J Transplant
. 2023 Jan;
23(2):165-170.
PMID: 36695696
For decades, transplantation has been a life-saving treatment for those fortunate enough to gain access. Nevertheless, many patients die waiting for an organ and countless more never make it onto...
6.
Reddy S, Punjala S, Allan P, Vaidya A, Borle D, Geiele H, et al.
Ann Surg
. 2022 Dec;
277(5):835-840.
PMID: 36468404
Objective: To report our experience with the combination of radical surgical excision and intestinal transplantation in patients with recurrent pseudomyxoma peritonei (PMP) not amenable to further cytoreductive surgery (CRS). Background:...
7.
Mohkam K, Nasralla D, Mergental H, Muller X, Butler A, Jassem W, et al.
Liver Transpl
. 2022 Jun;
28(11):1716-1725.
PMID: 35662403
In situ normothermic regional perfusion (NRP) and ex situ normothermic machine perfusion (NMP) aim to improve the outcomes of liver transplantation (LT) using controlled donation after circulatory death (cDCD). NRP...
8.
Shankar S, Beckett J, Tipton T, Ogbe A, Kasanyinga M, Dold C, et al.
J Am Soc Nephrol
. 2022 Apr;
33(5):883-887.
PMID: 35361708
No abstract available.
9.
Ramirez-Del Val A, Guarrera J, Porte R, Selzner M, Spiro M, Raptis D, et al.
Clin Transplant
. 2022 Mar;
36(10):e14638.
PMID: 35279883
Background: Recent evidence supports the use of machine perfusion technologies (MP) for marginal liver grafts. Their effect on enhanced recovery, however, remains uncertain. Objectives: To identify areas in which MP...
10.
Weissenbacher A, Stone J, Faro M, Hunter J, Ploeg R, Coussios C, et al.
Front Med (Lausanne)
. 2022 Jan;
8:801098.
PMID: 35083252
Kidney transplantation is the best renal-replacement option for most patients with end-stage renal disease. Normothermic machine preservation (NMP) of the kidney has been studied extensively during the last two decades...